2 x Life Science Hype Cycles - Michael Shanler

While the spring rains drenched the northeastern U.S. and parts of Europe, Jeff, Steve, and I were hard at work authoring, arranging, writing, reviewing, re-reviewing, re-re-reviewing our content. After countless cups of coffee, our 2 x hype cycles that cover the life science industry are finally published. These docs are relevant for CIOs, IT and business leaders that run organizations at pharma, biotech, med-device, and CROs. Roles representing other highly-regulated science-based product development industries (e.g. cosmetics, nutriceuticals, food & beverage) may also find these hype cycles interesting.

Keep in mind the relationship between these two documents-

The Hype Cycle for Life Sciences, 2017 is the over-arching hype cycle with technologies that span multiple business functions (e.g. sales, marketing, R&D, supply chain, etc).
The Hype Cycle for Life Science Research and Development, 2017 represents a sub-set of technologies that are important for R&D (e.g. drug discovery, clinical development, regulatory submission).

~80 technologies are covered in these 2 x hype cycles. Since “life science” is a bit of a moving target and we see disruption happening on the fringe with health care industry segments, it might pay to become familiar with these other HC docs, as well:

Of course, there are specialty non-industry specific hype cycles, too. For example:

The Gartner Blog Network provides an opportunity for Gartner analysts to test ideas and move research forward. Because the content posted by Gartner analysts on this site does not undergo our standard editorial review, all comments or opinions expressed hereunder are those of the individual contributors and do not represent the views of Gartner, Inc. or its management.